CNS Therapeutics Receives $50,000 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=161f8c99-83e7-4361-8540-0678bb180c5f&Preview=1 -
Date
4/28/2011 -
Company Name
CNS Therapeutics -
Mailing Address
332 Minnesota Street Saint Paul, MN 55101 -
Company Description
CNS Therapeutics develops and brings to market safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system. Gablofen (baclofen injection) marks first breakthrough for CNS Therapeutics. -
Website
http://www.gablofen.com -
Transaction Type
Venture Equity -
Transaction Amount
$50,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing – amended. -
M&A Terms
-
Venture Investor
Undisclosed
